Recent advances of antibody drug conjugates for clinical applications

Antibody drug conjugates (ADCs) normally compose of a humanized antibody and small molecular drug via a chemical linker. After decades of preclinical and clinical studies, a series of ADCs have been widely used for treating specific tumor types in the clinic such as brentuximab vedotin (Adcetris®) f...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Pengxuan, Zhang, Yuebao, Li, Wenqing, Jeanty, Christopher, Xiang, Guangya, Dong, Yizhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564033/
https://www.ncbi.nlm.nih.gov/pubmed/33088681
http://dx.doi.org/10.1016/j.apsb.2020.04.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564033/
https://www.ncbi.nlm.nih.gov/pubmed/33088681
http://dx.doi.org/10.1016/j.apsb.2020.04.012

Ejemplares similares